ACKR3 and diffuse large B-cell lymphoma: Our data showing the involvement of the LTB4/BLT1R axis in VAL cell migration, could open a way for the development of novel therapeutic approaches in the treatment of DLBCL, potentially in combination with inhibitors of ACKR3 (69–72).